- Sections
- C - Chimiemétallurgie
- C07H - Sucresleurs dérivésnucléosidesnucléotidesacides nucléiques
- C07H 23/00 - Composés contenant du bore, du silicium ou un métal, p. ex. chélates ou vitamine B12
Détention brevets de la classe C07H 23/00
Brevets de cette classe: 374
Historique des publications depuis 10 ans
|
26
|
32
|
32
|
25
|
17
|
19
|
29
|
29
|
26
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| American Regent, Inc. | 119 |
9 |
| Sumitomo Chemical Company, Limited | 9016 |
7 |
| Gilead Sciences, Inc. | 2222 |
7 |
| Agilent Technologies, Inc. | 2634 |
6 |
| Charles Sturt University | 21 |
6 |
| Fred Hutchinson Cancer Research Center | 343 |
5 |
| Renibus Therapeutics, Inc. | 69 |
5 |
| Wave Life Sciences Ltd. | 221 |
5 |
| The Regents of the University of California | 20745 |
4 |
| Centre National de La Recherche Scientifique | 11023 |
4 |
| FUJIFILM Corporation | 30514 |
4 |
| Biogen MA Inc. | 938 |
4 |
| Roche Sequencing Solutions, Inc. | 723 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
4 |
| VDF FutureCeuticals, Inc. | 153 |
4 |
| Akamara Therapeutics, Inc. | 12 |
4 |
| Singular Genomics Systems, Inc. | 328 |
4 |
| Northwestern University | 3543 |
3 |
| Cisbio Bioassays | 67 |
3 |
| Gudui Biopharma Technology Inc. | 7 |
3 |
| Autres propriétaires | 279 |